Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, sees markets in a "digestion phase" following the ...

Roger Altman, former deputy Treasury secretary and founder of Evercore, joins CNBC's 'Squawk Box' to discuss president-elect ...

Evercore ISI analyst Mark Lipacis raised the firm’s price target on Nvidia (NVDA) to $190 from $189 and keeps an Outperform rating on the shares. The firm continues to view Nvidia as a top pick post ...

Saudi Aramco's digital arm is in talks to take a significant minority stake in Mavenir, in a deal that is likely to value the ...

The Federal Reserve appears to be heading to a more wary and “hedged posture” on the rate and level of further rate cuts due ...

Evercore ISI analyst Cory Kasimov initiated coverage with a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price ...

New York-listed investment bank Evercore has sold its stake in Luminis Partners, ending an almost decade-long shareholding in ...

Evercore ISI upgraded BioNTech (BNTX) to Outperform from In Line with a price target of $125, up from $110. The firm says it has been “growing increasingly constructive for some time now.” ...

is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, Dec. 3, 2024, ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 7th ...

Evercore ISI’s price target would indicate a potential upside of 14.23% from the company’s current price. POST has been the subject of several other research reports.

Nov. 19, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conference on ...